Simultaneous and semi-automated determinations of theophylline, acetaminophen, and ethosuximide from human serum are possible through use of a programmable autoinjector, an isocratic mobile phase, and reversedphase 'high-performance" liquidchromatography on a .tBondapak C18 column. and high or protracted doses of acetaminophen has gained increasing importance for the therapeutic management of patients administered any one or more of these drugs (1) (2) (3) (4) (5) . Previous separate reversed-phase "highperformance" liquid-chromatographic (HPLC) assaysof these three drugs, though often complicated, have offered the advantages of accuracy and precision, no derivatization requirements, and a wide choice of solvent systems and chromatographic equipment (6) (7) (8) (9) (10) (11) .
Homogeneous enzyme immunoassays (EMIT; Syva Co., Palo Alto, CA 94304) for theophylline and ethosuximide are accurate and precise, and provide ease of procedural technique, batch capability, and rapid analyses, but at a significant cost (12) (13) (14) .
While assaying patient sera for theophylline by a standard liquid-chromatographic method (6), we had observed interference from a front-running peak, which caused these theophylline values to be significantly higher than theophylline values obtained by EMIT 
Materials and Methods

Reagents
Theophylline, theobromine, f3-hydroxyethyltheophylline, 
Mobile Phase
The acetonitrile/water (1/11, by vol) mobile phase is generated in 3-L batches in a fume hood by stirring 1.5 mL of acetic acid into 2.75 L of de-ionized water containing acetonitrile (250 mL) and triethylamine (2.0 mL). The solution is stored at 2-6 #{176}C. Before use, 1 L of this mobile phase is filtered at reduced pressure; the apparent pH should be 4.8 ± 0.3. Use of N-ethylmorpholine (2.0 mL) in lieu of triethylamine produced a similar HPLC elution pattern for these drugs.
Extraction Procedure
To 100 ML of each sample of patient's serum or blank serum to which aliquots of the standards have been added, pipet 10 ML of -hydroxyethyltheophylline standard, 100 ML of acetonitrile, and 1.0 mL of ethylacetate. Vortex mix for 20s, then centrifuge at 2500 X g for 2 mm. Transfer the organic (upper) layer to a fresh tube and evaporate it under a stream of nitrogen while warming in a water bath at 30 #{176}C. Dissolve the residues in 100 ML of acetonitrile/water (1/1, by vol) and centrifuge the extracts at 2500 X g for 2 mm. We then load the clear supernate into prelabeled WISP (Waters Associates, Milford, MA 01757) insert vials before autoinjection.
These operations, preparation of two control sera, and the loading of the low-and high-concentration drug standards take less than 30 mm, and yield an average HPLC recovery from the serum extracts of at least 80% for each drug.
HPLC Procedure
We performed the analyses with a Waters Associates MBondapak C18 column (3.9 X 300 mm; 1O-Mm particle size) attached in series from the input line to a WISP autoinjector (parameters set at 10 ML injection volumn, 8 mm run time, and 1 injection number) to a Waters Model 6000 solvent delivery unit pumping mobile phase at an isocratic flow of 2.5 mL/min. The output line of the column was connected to a Schoeffel variable wavelength detector (Kratos Corp., Westwood, NJ 07675) at a wavelength setting of 204 nm and a range of 0.02 absorbance units full-scale. All chromatograms were plotted with a Houston Instruments (Austin, TX 78753) single-pen recorder, run at a chart rate of 5.0 mm/mm. Figure 1 shows an example chromatogram of a drug-fortified serum sample chromatographed under these conditions. Quantitation was by the method of peak height ratios: we divided the peak heights of each drug by the concomitantly assayed peak height of f3-hydroxyethyltheophylline (the internal standard).
These calculated ratios were then compared with straight line plots developed from the peak height ratios for the low-and highconcentration standards to determine the concentration of drug in the patients' sera.
EMIT Procedure
The homogeneous enzyme immunoassay reagents (EMIT- 
acetaminophen,
theophylline, (8)/3-hydroxyethyltheophylline, (9)ethosuximide,(10)caffeine, and (11)8-chlorotheophylline Urea, aminophenol, acetic acid, triethylamine, N-ethylmorpholine, ethyl acetate, and acetonitrile were present but do not interfere with these peaks aad for theophylline and EMIT-aed for ethosuximide) were purchased from Syva, which supplies them in lyophilized form. After reconstitution with water, we used these reagents and calibrators within a week, storing them at 2-6 #{176}C between assays. We used a CentrifiChem System (Union Carbide, Pleasantville, NY 10570) for all EMIT determinations, assaying each serum sample in duplicate as specified in the EMIT (1976) package inserts.
Results and Discussion
A typical elution profile for these drugs and related substances extracted from serum was that shown in Figure 1 respectively (15, 16) . The low concentration point, on the other hand, was chosen to be within the therapeuticrange of these drugs. A best-fit evaluation of the acetaminophen two-point standard data (at 30 and 120 mg/L) for 12 trials yielded the standard linehaving a y-interceptof -0.08 and a ratio slope of 21.16. A similar 12-trial best-fit evaluation for
Theophylline(mg/L) by HPLC the ethosuximide two-point standards (at 30 and 120 mg/L) gave a y-intercept of -0.05 1 and a ratio slope of 73.5, and 15 trials of the theophylline two-point standards (at 8 and 32 mg/L) gave a best-fit analysis showing a y-intercept of 0.042 and a ratio slope of 0.0 125. The CVs for quantitation of these high and low standards for these three drugs were well below 6.5% in each of these trials, which with the low v-intercept values was evidence that adequate linearity was attained. SD, mg/L Table 2) did not reveal substantial differences between these techniques, but indicated slightly greater inaccuracy and less precision compared with the within-run results (Table 1) for both techniques. Both the HPLC and EMIT assays afforded adequate sensitivity towards low concentrations of theophylline and ethosuximide insera (Figures2 and 3) . Moreover, the correlation of acetaminophen as determined by this HPLC technique with 36 drug-added sera and control sera samples having known concentrations of acetaminophen added was also quite satisfactory ( Figure 4) . The y-intercept was close to zero and the slope close to 1 (r = 0.985).
The present HPLC method for these three drugs was useful forsmall sample numbers, with a turnaround time of 1 h for two patients, two controls, and two standards.
In addition, the overall cost of reagents (HPLC vs EMIT) was substantially less for the HPLC technique, although the EMIT system required less labor and allowed more efficient batching of specimens.
This (16) . We consider, however, that the EMIT system is useful in terms of speed and convenience when large numbers of samples must be assayed and when an automated kinetic analyzer such as the CentrifiChem is available.
We believe, therefore, that the high degree of correlation between the HPLC and the EMIT procedures for ethosuximide and theophylline is sufficient to allow both these methods to be used interchangeably, which facilitates the monitoring of patient sera for these drugs. Additionally, the present single-system HPLC method permits the concurrent evaluation of acetaminophen concentrations and provides the capability for collection of fractions, which can be completely cleared of volatile solvent and buffers by lyophilization, and thus simplifies isolation and characterization of metabolites and unknown substances. Finally, the properties of these ionpairing mobile phases ensure that the high-pressure fittings and valves of the autoinjector are protected from salt damage.
